Cargando…

Toll-Like Receptor 8 Agonist and Bacteria Trigger Potent Activation of Innate Immune Cells in Human Liver

The ability of innate immune cells to sense and respond to impending danger varies by anatomical location. The liver is considered tolerogenic but is still capable of mounting a successful immune response to clear various infections. To understand whether hepatic immune cells tune their response to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Juandy, Tan, Anthony T., Ussher, James E., Sandalova, Elena, Tang, Xin-Zi, Tan-Garcia, Alfonso, To, Natalie, Hong, Michelle, Chia, Adeline, Gill, Upkar S., Kennedy, Patrick T., Tan, Kai Chah, Lee, Kang Hoe, De Libero, Gennaro, Gehring, Adam J., Willberg, Christian B., Klenerman, Paul, Bertoletti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072808/ https://www.ncbi.nlm.nih.gov/pubmed/24967632 http://dx.doi.org/10.1371/journal.ppat.1004210

Ejemplares similares

Mucosal-Associated Invariant T-Cells: New Players in Anti-Bacterial Immunity
por: Ussher, James E., et al.
Publicado: (2014)

MAIT cells and viruses
por: Ussher, James E, et al.
Publicado: (2018)

Innate‐like CD8+ T‐cells and NK cells: converging functions and phenotypes
por: Kurioka, Ayako, et al.
Publicado: (2018)

Role of Cellular Immunity in Cow's Milk Allergy: Pathogenesis, Tolerance Induction, and Beyond
por: Jo, Juandy, et al.
Publicado: (2014)

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
por: Andón, Fernando Torres, et al.
Publicado: (2022)

Building and Optimizing a Virus-specific T Cell Receptor Library for Targeted Immunotherapy in Viral Infections
por: Banu, Nasirah, et al.
Publicado: (2014)

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
por: Ng, Oi-Wing, et al.
Publicado: (2016)

HBV-Specific Adaptive Immunity
por: Bertoletti, Antonio, et al.
Publicado: (2009)

Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response
por: Zeng, Qin, et al.
Publicado: (2022)

Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation
por: Rajekar, Harshal, et al.
Publicado: (2008)

P231 HEPATITIS C VIRUS POTENTLY ACTIVATES HUMAN CD161/MAIT (MUCOSAL ASSOCIATED INVARIANT T) CELLS
por: Thompson, F.M., et al.
Publicado: (2014)

TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014)

Innate immunity and Toll-like receptors
por: O'Neill, LAJ
Publicado: (2004)

Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs
por: Vargas-Caraveo, Alejandra, et al.
Publicado: (2020)

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
por: Zeng, Georgia, et al.
Publicado: (2020)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Neonatal innate immunity and Toll-like receptor
por: Yoon, Hye Sun
Publicado: (2010)

Toll-Like Receptors in Antiviral Innate Immunity
por: Lester, Sandra N., et al.
Publicado: (2014)

The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes
por: Ganapathi, Lakshmi, et al.
Publicado: (2015)

Trained immunity in newborn infants of HBV-infected mothers
por: Hong, Michelle, et al.
Publicado: (2015)

Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway
por: Lu, Xing, et al.
Publicado: (2023)

Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans
por: Sandalova, Elena, et al.
Publicado: (2010)

Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection
por: Gehring, Adam J., et al.
Publicado: (2011)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET
por: Ma, Jihong, et al.
Publicado: (2021)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

Toll, A New Piece in the Puzzle of Innate Immunity
por: Wright, Samuel D.
Publicado: (1999)

Innate Immune Regulation by Toll-Like Receptors in the Brain
por: Mallard, Carina
Publicado: (2012)

Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
por: Downer, Eric J.
Publicado: (2011)

Melanogenesis Connection with Innate Immunity and Toll-Like Receptors
por: Koike, Saaya, et al.
Publicado: (2020)

Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma
por: Zaki, Marco Y. W., et al.
Publicado: (2022)

Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
por: Dowling, David J., et al.
Publicado: (2017)

The Role of Innate Immunity in Autoimmunity
por: Bach, Jean-François, et al.
Publicado: (2004)

Repertoire of Escherichia coli agonists sensed by innate immunity receptors of the bovine udder and mammary epithelial cells
por: Porcherie, Adeline, et al.
Publicado: (2012)

The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
por: Dowling, David J., et al.
Publicado: (2013)

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes
por: Janovec, Vaclav, et al.
Publicado: (2020)

Early Treatment Consideration in Patients with Hepatitis B ‘e’ Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?
por: Koffas, Apostolos, et al.
Publicado: (2022)

Conditional ligands for Asian HLA variants facilitate the definition of CD8(+) T‐cell responses in acute and chronic viral diseases
por: Chang, Cynthia X. L., et al.
Publicado: (2013)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9p2fh2ntu5q921hifrrqs4hd9j